FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135817853> ?p ?o ?g. }

• W3135817853 endingPage "76" @default.
• W3135817853 startingPage "70" @default.
• W3135817853 abstract "T cells secrete several inflammatory cytokines that play a critical role in the progression of atherosclerosis. Although green tea epigallocatechin-3-gallate (EGCG) exerts anti-inflammatory and anti-atherosclerotic effects in animals, few studies have identified the mechanism underlying these effects in human primary T cells. This study investigated the pathway involved in EGCG modulation of cytokine secretion in activated human primary T cells. We pre-treated human primary T cells with EGCG (0.1, 1, 5, 10, and 20 μM) for 4 h and incubated them with or without phorbol 12-myristate 13-acetate and ionomycin (P/I) for 20 h. The cytokine production, activator protein (AP)-1 binding activity, and level of mitogen-activated protein kinase (MAPK) were assessed using enzyme-linked immunosorbent assay, electrophoretic mobility shift assay, and Western blotting, respectively. At 10 and 20 μM, EGCG decreased interleukin (IL)-2 levels by 26.0% and 38.8%, IL-4 levels by 41.5% and 55.9%, INF-γ levels by 31.3% and 34.7%, and tumor-necrosis factor (TNF)-α levels by 23.0% and 37.6%, respectively. In addition, the level of phosphorylated c-Jun N-terminal (p-JNK) and extracellular signal-regulated kinase (p-ERK) was decreased, but not the level of p-p38 MAPK. EGCG did not alter any of the total protein amounts, suggesting a selective effect on specific types of MAPKs in stimulated human T cells. EGCG tended to inactivate AP-1 DNA-binding activity. The P/I-induced production of IL-2, IL-4, INF-γ, and TNF-α by human T cells was suppressed by AP-1 inhibitor in a concentration-dependent manner. In conclusion, EGCG suppressed cytokine secretion in activated human primary T cells, and this effect was likely mediated by AP-1 inactivation through the ERK and JNK, but not p38 MAPK, pathways. These results may be related to the mechanisms through which EGCG inhibits immune- or inflammation-related atherogenesis." @default.
• W3135817853 created "2021-03-15" @default.
• W3135817853 creator A5004754498 @default.
• W3135817853 creator A5012140290 @default.
• W3135817853 creator A5016871377 @default.
• W3135817853 creator A5040370641 @default.
• W3135817853 creator A5058823359 @default.
• W3135817853 creator A5059529488 @default.
• W3135817853 creator A5067588058 @default.
• W3135817853 creator A5077935418 @default.
• W3135817853 creator A5083739687 @default.
• W3135817853 creator A5084207601 @default.
• W3135817853 creator A5087206403 @default.
• W3135817853 date "2021-04-01" @default.
• W3135817853 modified "2023-10-18" @default.
• W3135817853 title "Epigallocatechin-3-gallate exhibits immunomodulatory effects in human primary T cells" @default.
• W3135817853 cites W1488002178 @default.
• W3135817853 cites W1971417259 @default.
• W3135817853 cites W1973179668 @default.
• W3135817853 cites W1993172216 @default.
• W3135817853 cites W1994931365 @default.
• W3135817853 cites W1997756128 @default.
• W3135817853 cites W1999108312 @default.
• W3135817853 cites W1999742425 @default.
• W3135817853 cites W2001260591 @default.
• W3135817853 cites W2006288978 @default.
• W3135817853 cites W2008490492 @default.
• W3135817853 cites W2008960002 @default.
• W3135817853 cites W2013657760 @default.
• W3135817853 cites W2017921920 @default.
• W3135817853 cites W2027147047 @default.
• W3135817853 cites W2033896075 @default.
• W3135817853 cites W2066501941 @default.
• W3135817853 cites W2070785261 @default.
• W3135817853 cites W2079724669 @default.
• W3135817853 cites W2088092773 @default.
• W3135817853 cites W2088130684 @default.
• W3135817853 cites W2091173515 @default.
• W3135817853 cites W2094629035 @default.
• W3135817853 cites W2098537370 @default.
• W3135817853 cites W2104973990 @default.
• W3135817853 cites W2107545656 @default.
• W3135817853 cites W2123780620 @default.
• W3135817853 cites W2136208700 @default.
• W3135817853 cites W2156593520 @default.
• W3135817853 cites W2165037318 @default.
• W3135817853 cites W2168987230 @default.
• W3135817853 cites W2291759964 @default.
• W3135817853 cites W2332332617 @default.
• W3135817853 cites W4378980606 @default.
• W3135817853 doi "https://doi.org/10.1016/j.bbrc.2021.02.132" @default.
• W3135817853 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33689882" @default.
• W3135817853 hasPublicationYear "2021" @default.
• W3135817853 type Work @default.
• W3135817853 sameAs 3135817853 @default.
• W3135817853 citedByCount "20" @default.
• W3135817853 countsByYear W31358178532021 @default.
• W3135817853 countsByYear W31358178532022 @default.
• W3135817853 countsByYear W31358178532023 @default.
• W3135817853 crossrefType "journal-article" @default.
• W3135817853 hasAuthorship W3135817853A5004754498 @default.
• W3135817853 hasAuthorship W3135817853A5012140290 @default.
• W3135817853 hasAuthorship W3135817853A5016871377 @default.
• W3135817853 hasAuthorship W3135817853A5040370641 @default.
• W3135817853 hasAuthorship W3135817853A5058823359 @default.
• W3135817853 hasAuthorship W3135817853A5059529488 @default.
• W3135817853 hasAuthorship W3135817853A5067588058 @default.
• W3135817853 hasAuthorship W3135817853A5077935418 @default.
• W3135817853 hasAuthorship W3135817853A5083739687 @default.
• W3135817853 hasAuthorship W3135817853A5084207601 @default.
• W3135817853 hasAuthorship W3135817853A5087206403 @default.
• W3135817853 hasBestOaLocation W31358178531 @default.
• W3135817853 hasConcept C104317684 @default.
• W3135817853 hasConcept C134018914 @default.
• W3135817853 hasConcept C153911025 @default.
• W3135817853 hasConcept C170493617 @default.
• W3135817853 hasConcept C17991360 @default.
• W3135817853 hasConcept C183978625 @default.
• W3135817853 hasConcept C184235292 @default.
• W3135817853 hasConcept C185592680 @default.
• W3135817853 hasConcept C203014093 @default.
• W3135817853 hasConcept C24998067 @default.
• W3135817853 hasConcept C2776989580 @default.
• W3135817853 hasConcept C2778690821 @default.
• W3135817853 hasConcept C28406088 @default.
• W3135817853 hasConcept C49039625 @default.
• W3135817853 hasConcept C51551487 @default.
• W3135817853 hasConcept C55493867 @default.
• W3135817853 hasConcept C57074206 @default.
• W3135817853 hasConcept C86339819 @default.
• W3135817853 hasConcept C86803240 @default.
• W3135817853 hasConcept C88045685 @default.
• W3135817853 hasConcept C97029542 @default.
• W3135817853 hasConceptScore W3135817853C104317684 @default.
• W3135817853 hasConceptScore W3135817853C134018914 @default.
• W3135817853 hasConceptScore W3135817853C153911025 @default.
• W3135817853 hasConceptScore W3135817853C170493617 @default.
• W3135817853 hasConceptScore W3135817853C17991360 @default.

• next